FTRE

#1855
Fortrea Holdings Inc. - Common Stock
15.3 9 USD
+3.57%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
15.39
15.39
年范围
3.97
18.67
日变化
+3.57%
每月变动
+46.15%
6个月变化
+23.42%
年变化
+269.95%
前一天收盘价
14.8 6
Open
15.3 9
最低价
15.3 9
High
15.3 9
交易量
116
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 1.46 B
  • Employee 14 K
  • Founded 2023
  • CEO Paul R. N. Kirchgraber
  • Website www.fortrea.com
  • Headquarter North Carolina, United States
  • FIGI BBG01GZF9VY6
  • Industry 生物技术
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.6
市销率
—

Fortrea Holdings Inc. - Common Stock

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates.

新闻